These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis. Thomas T; Lafage MH; Alexandre C J Rheumatol; 1995 Nov; 22(11):2183-5. PubMed ID: 8596168 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of postmenopausal osteoporosis with etidronate]. Terranova R; Luca S Minerva Med; 1999 Mar; 90(3):85-90. PubMed ID: 10432959 [TBL] [Abstract][Full Text] [Related]
25. Drugs for prevention and treatment of postmenopausal osteoporosis. Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622 [No Abstract] [Full Text] [Related]
26. [To treat effectively without delay. The data on fractures decisive]. MMW Fortschr Med; 2003 May; 145(21):56-7. PubMed ID: 12845873 [No Abstract] [Full Text] [Related]
27. Treatment options for postmenopausal osteoporosis. Singer F Hawaii Med J; 1994 Sep; 53(9):256-7, 260-1. PubMed ID: 7960721 [No Abstract] [Full Text] [Related]
28. [To increase bone density faster and stronger]. MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589 [No Abstract] [Full Text] [Related]
30. Iatrogenic osteoporosis. Hamdy RC South Med J; 1999 Nov; 92(11):1131-3. PubMed ID: 10586849 [No Abstract] [Full Text] [Related]
31. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. Storm T; Kollerup G; Thamsborg G; Genant HK; Sørensen OH J Rheumatol; 1996 Sep; 23(9):1560-4. PubMed ID: 8877926 [TBL] [Abstract][Full Text] [Related]
32. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Brown JP; Kendler DL; McClung MR; Emkey RD; Adachi JD; Bolognese MA; Li Z; Balske A; Lindsay R Calcif Tissue Int; 2002 Aug; 71(2):103-11. PubMed ID: 12085156 [TBL] [Abstract][Full Text] [Related]
34. Risedronate: a new bisphosphonate for the treatment of osteoporosis. Kessenich CR Nurse Pract; 2000 Mar; 25(3):106-8. PubMed ID: 10750124 [No Abstract] [Full Text] [Related]
36. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis. Loeliger EA Am J Med; 1995 Aug; 99(2):225-6. PubMed ID: 7677912 [No Abstract] [Full Text] [Related]
37. [Study indites calcium as a heart breaker. 30 % more myocardial infarcts caused by high dosage calcium preparations]. Kinderkrankenschwester; 2013 Mar; 32(3):114. PubMed ID: 23600116 [No Abstract] [Full Text] [Related]
38. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Cramer JA; Amonkar MM; Hebborn A; Altman R Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664 [TBL] [Abstract][Full Text] [Related]